Evidence map›Paper›PMID 31952629›Full record

ArticleJournal of substance abuse treatment2020

"Now hospital leaders are paying attention": A qualitative study of internal and external factors influencing addiction consult services.

Kelsey C Priest, Honora Englander, Dennis McCarty

Open access · greenAbstract read
In one paragraph

Article in Journal of substance abuse treatment, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 52 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Kelsey C PriestSchool of Medicine, MD/PhD Program, Oregon Health & Science University, United States; School of Public Health, Oregon Health & Science University-Portland State University, United States. Electronic address: priest@ohsu.edu.
Honora EnglanderDivision of Hospital Medicine, Department of Medicine, Oregon Health & Science University, Portland, OR, United States; Section of Addiction Medicine, Division of General Internal Medicine, Department of Medicine, Oregon Health & Science University, Portland, OR, United States.
Dennis McCartySchool of Public Health, Oregon Health & Science University-Portland State University, United States.
Oregon Health & Science University · US

Funding

Western States Node of the National Drug Abuse Treatment Clinical Trials Network (TMS for CUD) UG1DA015815 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Keith N. Humphreys, Philip Todd Korthuis · 2015 to 2026
$24.6M
Oregon's Coordinated Care Organizations Integrate Care for Drug Use DisordersR33DA035640 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI LIND, BONNIE · 2014 to 2017
$2.4M
Variation in the Use of Opioid Agonist Treatment in HospitalsF30DA044700 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI PRIEST, KELSEY CAROLINE · 2017 to 2020
$186k
NIDA NIH HHS F30 DA044700NIDA NIH HHS R33 DA035640NIDA NIH HHS UG1 DA015815
6 · The paper itself

Abstract

backgroundHospitalizations related to opioid use disorder (OUD) are increasing, necessitating an increase in the delivery of opioid agonist therapy (OAT) among hospitalized adults. The addiction consult service (ACS) is a promising organizational intervention to address this growing clinical need. Little is known about the barriers and facilitators of ACS development and operations.

methodsWe completed 17 semi-structured telephone interviews with board-certified or board-eligible addiction physicians across 16 U.S. acute care hospitals. Interviews explored contextual facilitators and barriers for ACS development and operations. We transcribed, coded, analyzed interviews, and derived final themes using a directed content analysis.

resultsWe identified six themes that promoted or inhibited ACS development and operations: 1) stigma and discrimination; 2) internal (e.g., hospital administrators) and external stakeholders (e.g., State Medicaid programs); 3) addiction-informed institutions with addiction-related resources; 4) access to community-based treatment programs (e.g., local opioid treatment programs); 5) restrictive and misinterpreted OAT policies; and 6) service financing. The first theme, stigma and discrimination, is presented as a stand-alone-theme but permeates the five other themes as a broader meta-theme.

conclusionsAs OUD-related hospitalizations increase, and the opioid-related overdose crisis continues, understanding the constraints related to the development and operations of ACSs are important preliminary steps for improving the care of patients hospitalized with OUD. Clinical champions, hospital leaders, and hospital societies could act, through practice and policy initiatives, to support ACS development and increase the delivery of evidence-based services (e.g., OAT) to patients hospitalized with OUD.

Indexed as

BuprenorphineOpioid-Related DisordersAdultAttentionHospitalsHumansOpiate Substitution TreatmentOpioid EpidemicUnited StatesBuprenorphineAddiction consult serviceAddiction medicine consult serviceBuprenorphineMethadoneOpioid agonist therapyOpioid use disorder

Identifiers

PMID31952629
PMCPMC7181883
OpenAlexW2992932129

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.